# Vaccine developer Bharat Biotech International Ltd is exploring to raise over $500 million through an initial public offering, according to a Bloomberg report.

*biotech · news · 2026-02-27 · Livemint*

## Key points

- Bharat Biotech is considering raising over $500 million via an initial public offering.
- Bharat Biotech signed a Technology Transfer Agreement with Biofabri to make and supply MTBVAC.
- Bharat Biotech will produce MTBVAC for tuberculosis for over 70 countries in Africa and Southeast Asia.
- Biovet, a Bharat Biotech group company, received the world’s first LSD vaccine license for dairy cattle.

**Companies:** Bharat Biotech International Ltd, Serum Institute of India
**Countries:** India, Spain

[Read the full story on Livemint](https://www.livemint.com/market/ipo/bharat-biotech-ipo-soon-vaccine-maker-plans-to-raise-500-million-from-stock-market-says-report-11772208161131.html)

---

Canonical: https://newsio.io/n/bed1b5a2-34e1-4dbc-bc98-20e8912239ad/vaccine-developer-bharat-biotech-international-ltd-is-exploring-to-raise-over-50
Summarized by Newsio from Livemint. https://newsio.io/how-it-works